Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$41.68
0.240.58%
At Close: -
$41.25
-0.43-1.03%
After Hours: Aug 23, 5:16 PM EDT
15 minutes delayed
Comments
Loading...
Protagonist Therapeutics (PTGX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Good
Protagonist Therapeutics (NASDAQ:PTGX) Stock Quotes, Forecast and News Summary
Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.
| Open | $41.70 |
| Close | $41.68 |
| Volume / Avg. | 698.05K / 973.21K |
| Day Range | $40.80 - $41.85 |
| 52 Wk Range | 13.72 - 42.67 |
| Market Cap | $2.43B |
| P/E Ratio | 15.24 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 63 |
| Short Interest | 5% |
| Days to Cover | 4.23 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Protagonist Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary tech...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Protagonist Therapeutics (PTGX) stock?
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Who are Protagonist Therapeutics (PTGX) competitors?
Other companies in Protagonist Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals (NASDAQ:AGIO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
What is the forecast, or price target, for Protagonist Therapeutics (PTGX) stock?
Protagonist Therapeutics has a consensus price target of $46.70.
What is the current price for Protagonist Therapeutics (PTGX)?
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $41.25 last updated August 23, 2024 at 5:16 PM EDT.
Does Protagonist Therapeutics (PTGX) pay a dividend?
There are no upcoming dividends for Protagonist Therapeutics.
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Protagonist Therapeutics (PTGX) going to split?
There is no upcoming split for Protagonist Therapeutics.
What sector and industry does Protagonist Therapeutics (PTGX) operate in?
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.